echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > Help prevent nausea and vomiting caused by anti-tumor drugs CDE plans to release new clinical trial regulations

    Help prevent nausea and vomiting caused by anti-tumor drugs CDE plans to release new clinical trial regulations

    • Last Update: 2021-09-04
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    In the third week of August 2021, it was ridiculed by the pharmaceutical industry as "Homework Assignment Week".


    1.


    1.


    Nausea and vomiting are common adverse reactions of anti-tumor drugs.


    The CDE was launched in January 2021, and the first draft was formed in May 2021.


    2.


    2.


    At present, according to the time of appearance of nausea and vomiting, it is divided into the following three categories, which are summarized in the following table:

    3.


    3.


    2.


    3.


    references

    references

    [1]http://

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.